[2] The company is listed on the Nasdaq stock exchange in the United States, and As of June 2023[update] had approximately 41,160 employees in 108 locations spread across 53 countries.
[6] In 2013, PRA Health Sciences was acquired by KKR, which listed the company on the Nasdaq in November 2014 and maintained shares until September 2019.
[10] In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON.
[11] He had previously been with Quintiles South Africa, Sandoz AG, and Kendle Intl Inc, before joining ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014.
[13] ICON enjoyed success in multiple categories at the Clinical Research Organisation leadership awards,[14] consecutively from 2018 - 2023, determined by Life Science Leader magazine and Industry Standard Research (ISR).